حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
AlzChem Group AG
ACTAlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. The company was founded in 1908 and is based in Trostberg, Germany. Address: Dr.-Albert-Frank-Strasse 32, Trostberg, Germany, 83308
Analytics
سعر الهدف في وول ستريت
24.63 EURنسبة السعر إلى الأرباح
10.935العائد الربحي
2.1 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية ACT
تحليلات الأرباح ACT
نمو الأرباح على مدى 5 سنوات
-5 %النمو المستمر
3 سنينمعدل الدفع 5 سنوات في المتوسط
37 %تاريخ الأرباح ACT
تقييم الأسهم ACT
المالية ACT
نتائج | 2019 | ديناميات |